View in EDS

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
Authors: Kelly, R. J.1, Thomas, A.2, Rajan, A.2, Chun, G.2, Lopez-Chavez, A.2, Szabo, E.3, Spencer, S.2, Carter, C. A.4, Guha, U.2, Khozin, S.2, Poondru, S.5, Van Sant, C.5, Keating, A.5, Steinberg, S. M.6, Figg, W.2, Giaccone, G.2
Source: Annals of Oncology. Oct2013, Vol. 24 Issue 10, p2601-2606. 6p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdt249